ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Evolutionary Assembly and Future Design of Gibberellin Signaling.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Gibberellin (GA) signaling is widely regarded as a canonical hormone-controlled growth pathway, yet accumulating evidence suggests that it emerged through stepwise evolutionary assembly rather than as a pre-formed regulatory system. Here, we revisit the origin and diversification of the GA pathway from an evolutionary perspective. DELLA-mediated growth repression arose during early land plant evolution and was later integrated into a hormone-responsive framework following the establishment of GA biosynthesis and perception. The emergence of the receptor GID1 completed the core GA-GID1-DELLA module, enabling dynamic hormonal control of plant growth. Subsequent diversification of this module underpinned key agricultural innovations, including the semi-dwarf traits of the Green Revolution. However, manipulation of GA signaling also exposed trade-offs, particularly between reduced plant height and nitrogen use efficiency (NUE). Recent advances reveal additional regulatory nodes linking GA signaling to metabolic and stress-responsive networks, highlighting the importance of precise hormonal fine-tuning. Looking forward, we propose that integrating comparative genomics, structural biology, protein language models, and artificial intelligence may enable rational rewiring of GA signaling, providing a blueprint for engineering climate-resilient and resource-efficient crops.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.